Literature DB >> 6491907

Kinetics of partitioning and binding of digoxin and its analogues in the subcompartments of blood.

P H Hinderling.   

Abstract

The kinetics of digoxin and analogues (metabolites) in the subcompartments of blood, erythrocytes and plasma, were first order and concentration independent. The rate and extent of red blood cell partitioning of the tested compounds were, according to first-order kinetics, identical in the presence and absence of structurally related compounds and dependent on lipophilicity and temperature; red blood cell penetration was a reversible process. Erythrocyte partitioning of digoxin and its analogues was postulated to be by passive diffusion. There was significant intracellular binding of the compounds, and hemoglobin was the major ligand. The kinetics of red blood cell partitioning of the individual compounds were fitted according to a closed two- or three-compartment modeL. The latter indicated the existence of two kinetically separable compartments within the red blood cells. Model-independent mean transit times of red blood cell-plasma water partitioning of the compounds depended largely on the lipophilicity and were a thousand times greater for the least lipophilic analogues than for the most lipophilic derivatives. Red blood cell partitioning of digoxin and its metabolites under in vivo and in vitro conditions, were equivalent. Plasma protein binding of the tested compounds was concentration independent, unaltered in the presence of the analogues, and temperature independent between 24 degrees C and 37 degrees C. Binding to albumin in buffer solution was significantly larger than to albumin in plasma for all the compounds. Binding of digoxin and its analogues to albumin in buffer solution increased with increasing lipophilicity of the compounds.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6491907     DOI: 10.1002/jps.2600730807

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  Plasma protein binding of amiodarone in a patient population: measurement by erythrocyte partitioning and a novel glass-binding method.

Authors:  M E Veronese; S McLean; R Hendriks
Journal:  Br J Clin Pharmacol       Date:  1988-12       Impact factor: 4.335

2.  Quantitative relationships between structure and pharmacokinetics of beta-adrenoceptor blocking agents in man.

Authors:  P H Hinderling; O Schmidlin; J K Seydel
Journal:  J Pharmacokinet Biopharm       Date:  1984-06

3.  Clinical validation and implications of dried blood spot sampling of carbamazepine, valproic acid and phenytoin in patients with epilepsy.

Authors:  Sing Teang Kong; Shih-Hui Lim; Wee Beng Lee; Pasikanthi Kishore Kumar; Hwee Yi Stella Wang; Yan Lam Shannon Ng; Pei Shieen Wong; Paul C Ho
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

4.  Pharmacokinetic profile and partitioning in red blood cells of romifidine after single intravenous administration in the horse.

Authors:  Noemi Romagnoli; Khaled M Al-Qudah; Sara Armorini; Carlotta Lambertini; Anna Zaghini; Alessandro Spadari; Paola Roncada
Journal:  Vet Med Sci       Date:  2017-07-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.